Latest Commercialisation News

Astral Resources reports robust exploration results across its Western Australian gold projects and key progress on the Mandilla Definitive Feasibility Study, alongside a new joint venture at the Think Big deposit.

Korab Resources has completed key geophysical surveys at its Rum Jungle Project and progressed pre-feasibility studies for magnesium products, while navigating ASX suspension and pursuing asset divestments.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

Tempest Minerals reports significant progress at its Yalgoo iron deposit and Mount Magnet gold projects, with new drilling programs and promising targets identified.

Papyrus Australia has taken a major step towards commercialisation by signing a $4.2 million binding Terms Sheet with TBS Mining Solutions and progressing a high-volume production facility in Vietnam. The company also secured a $250,000 government grant and restructured its leadership to support growth.

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.

Identitii Limited has signed six new data sharing agreements with NSW clubs, expanded its BNDRY platform capabilities, and welcomed major shareholder Cameron Beavis to its board, signaling strong momentum ahead.

Lakes Blue Energy marked a pivotal quarter with its ASX reinstatement, a $5.8 million capital raise, and completion of the Wombat-5 well, setting the stage for imminent production testing and resource upgrades.

Altech Batteries has launched immediate sales of sodium nickel chloride batteries through a strategic collaboration with AMPower, while advancing its flagship CERENERGY project in Germany with strong funding and prototype milestones.

4DMedical Limited has secured FDA clearance and immediate Medicare reimbursement for its groundbreaking CT – VQ™ lung imaging technology, accelerating commercial adoption across the US, Brazil, and Australia.

Impact Minerals secures an 80% stake in the Lake Hope High Purity Alumina project following a robust Pre-Feasibility Study, while progressing pilot plant commissioning and a strategic joint venture in NSW.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.